Valiant Laboratories Limited (NSE:VALIANTLAB)
India
· Delayed Price · Currency is INR 54.95
-0.82 (-1.47%)
Mar 10, 2026, 10:40 AM IST
Valiant Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Cash & Equivalents | - | 49.17 | 117.18 | 12.62 | 1.31 |
| Short-Term Investments | - | 714.79 | 1,321 | 340.99 | - |
| Cash & Short-Term Investments | 629.06 | 763.96 | 1,438 | 353.6 | 1.31 |
| Cash Growth | -47.13% | -46.88% | 306.74% | 26830.85% | - |
| Accounts Receivable | - | 721.22 | 457.27 | 885.68 | 1,108 |
| Other Receivables | - | 2.51 | 18.74 | 7.22 | 0.08 |
| Receivables | - | 724.34 | 476.31 | 893.61 | 1,108 |
| Inventory | - | 39.89 | 100.15 | 130.42 | 158.04 |
| Prepaid Expenses | - | 1.51 | 1.44 | 5.19 | 1.52 |
| Other Current Assets | - | 396.48 | 239.3 | 122.96 | 228.56 |
| Total Current Assets | - | 1,926 | 2,255 | 1,506 | 1,497 |
| Property, Plant & Equipment | - | 2,041 | 927.03 | 487.98 | 236.72 |
| Long-Term Investments | - | - | - | - | 4.02 |
| Other Intangible Assets | - | 1.08 | - | - | - |
| Other Long-Term Assets | - | 40.22 | 244.41 | 135.89 | 6.1 |
| Total Assets | - | 4,009 | 3,427 | 2,130 | 1,744 |
| Accounts Payable | - | 407.16 | 259.27 | 472.96 | 397.24 |
| Accrued Expenses | - | 18.11 | 12.39 | 19.05 | - |
| Short-Term Debt | - | 168.56 | 13.88 | - | - |
| Current Portion of Long-Term Debt | - | - | - | - | 12.81 |
| Current Portion of Leases | - | 2.31 | 2.31 | 1.75 | 1.78 |
| Other Current Liabilities | - | 0.02 | 2.92 | 13.49 | 8.37 |
| Total Current Liabilities | - | 596.16 | 290.77 | 507.26 | 420.21 |
| Long-Term Debt | - | 1,043 | 746.63 | 594 | 594 |
| Long-Term Leases | - | 2.51 | 4.27 | 6.42 | 2.67 |
| Long-Term Deferred Tax Liabilities | - | 12.42 | 6.18 | 6.66 | 2.96 |
| Other Long-Term Liabilities | - | 10.9 | 10.42 | 10.4 | 9.61 |
| Total Liabilities | - | 1,665 | 1,058 | 1,125 | 1,029 |
| Common Stock | - | 434.5 | 434.5 | 325.6 | 162.8 |
| Additional Paid-In Capital | - | 1,410 | 1,413 | 163.39 | - |
| Retained Earnings | - | 498.81 | 520.87 | 515.92 | - |
| Comprehensive Income & Other | - | -0.19 | - | - | 551.8 |
| Shareholders' Equity | 3,173 | 2,343 | 2,369 | 1,005 | 714.6 |
| Total Liabilities & Equity | - | 4,009 | 3,427 | 2,130 | 1,744 |
| Total Debt | 537.69 | 1,217 | 767.08 | 602.18 | 611.26 |
| Net Cash (Debt) | 91.37 | -452.91 | 671.15 | -248.58 | -609.95 |
| Net Cash Per Share | 1.77 | -10.42 | 17.66 | -7.63 | -18.73 |
| Filing Date Shares Outstanding | 54.28 | 43.45 | 43.45 | 32.56 | 32.56 |
| Total Common Shares Outstanding | 54.28 | 43.45 | 43.45 | 32.56 | 32.56 |
| Working Capital | - | 1,330 | 1,965 | 998.52 | 1,077 |
| Book Value Per Share | 63.44 | 53.93 | 54.51 | 30.86 | 21.95 |
| Tangible Book Value | 3,173 | 2,342 | 2,369 | 1,005 | 714.6 |
| Tangible Book Value Per Share | 63.42 | 53.90 | 54.51 | 30.86 | 21.95 |
| Land | - | 226.48 | 226.48 | 226.48 | - |
| Buildings | - | 122.29 | 121.99 | 120.09 | 95.24 |
| Machinery | - | 341.29 | 338.37 | 301.26 | 147.47 |
| Construction In Progress | - | 1,558 | 426.49 | 6.8 | 14.45 |
Source: S&P Capital IQ. Standard template. Financial Sources.